Cvitkovic E - Search Results

1

Oxaliplatin clinical activity: a review.

Misset JL, Bleiberg H, Sutherland W, Bekradda M, Cvitkovic E. Misset JL, et al. Among authors: cvitkovic e. Crit Rev Oncol Hematol. 2000 Aug;35(2):75-93. doi: 10.1016/s1040-8428(00)00070-6. Crit Rev Oncol Hematol. 2000. PMID: 10936465 Review.

2

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.

Soulié P, Bensmaïne A, Garrino C, Chollet P, Brain E, Fereres M, Jasmin C, Musset M, Misset JL, Cvitkovic E. Soulié P, et al. Among authors: cvitkovic e. Eur J Cancer. 1997 Aug;33(9):1400-6. doi: 10.1016/s0959-8049(97)00122-6. Eur J Cancer. 1997. PMID: 9337681 Clinical Trial.

3

Oxaliplatin for the treatment of advanced colorectal cancer: future directions.

Ducreux M, Louvet C, Bekradda M, Cvitkovic E. Ducreux M, et al. Among authors: cvitkovic e. Semin Oncol. 1998 Apr;25(2 Suppl 5):47-53. Semin Oncol. 1998. PMID: 9609108 Review.

4

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients.

Germann N, Brienza S, Rotarski M, Emile JF, Di Palma M, Musset M, Reynes M, Soulié P, Cvitkovic E, Misset JL. Germann N, et al. Among authors: cvitkovic e. Ann Oncol. 1999 Mar;10(3):351-4. doi: 10.1023/a:1008310708853. Ann Oncol. 1999. PMID: 10355582 Free article. Clinical Trial.

5

Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.

Wasserman E, Cuvier C, Lokiec F, Goldwasser F, Kalla S, Méry-Mignard D, Ouldkaci M, Besmaine A, Dupont-André G, Mahjoubi M, Marty M, Misset JL, Cvitkovic E. Wasserman E, et al. Among authors: cvitkovic e. J Clin Oncol. 1999 Jun;17(6):1751-9. doi: 10.1200/JCO.1999.17.6.1751. J Clin Oncol. 1999. PMID: 10561212 Clinical Trial.

6

Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.

Soulié P, Garrino C, Bensmaïne MA, Bekradda M, Brain E, Di Palma M, Goupil A, Misset JL, Cvitkovic E. Soulié P, et al. Among authors: cvitkovic e. J Cancer Res Clin Oncol. 1999 Dec;125(12):707-11. doi: 10.1007/s004320050338. J Cancer Res Clin Oncol. 1999. PMID: 10592105 Clinical Trial.

7

Oxaliplatin: a new therapeutic option in colorectal cancer.

Cvitkovic E, Bekradda M. Cvitkovic E, et al. Semin Oncol. 1999 Dec;26(6):647-62. Semin Oncol. 1999. PMID: 10606258 Review.

8

Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients.

Goldwasser F, Gross-Goupil M, Tigaud JM, Di Palma M, Marceau-Suissa J, Wasserman E, Yovine A, Misset JL, Cvitkovic E. Goldwasser F, et al. Among authors: cvitkovic e. Ann Oncol. 2000 Nov;11(11):1463-70. doi: 10.1023/a:1026535824044. Ann Oncol. 2000. PMID: 11142487 Free article. Clinical Trial.

9

Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer.

Delaloge S, Laadem A, Taamma A, Chouaki N, Cvitkovic E, Pautier P, Misset JL, Lhommé C. Delaloge S, et al. Among authors: cvitkovic e. Am J Clin Oncol. 2000 Dec;23(6):569-74. doi: 10.1097/00000421-200012000-00007. Am J Clin Oncol. 2000. PMID: 11202798 Clinical Trial.

10

Feasibility of high-dose platinum delivery with combined carboplatin and oxaliplatin.

Llory JF, Soulie P, Cvitkovic E, Misset JL. Llory JF, et al. Among authors: cvitkovic e. J Natl Cancer Inst. 1994 Jul 20;86(14):1098-9. doi: 10.1093/jnci/86.14.1098. J Natl Cancer Inst. 1994. PMID: 8043147 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters